Wednesday, February 18, 2026 2/18/2026

Alpha2/delta1- thrombospondin-3 signaling in the central control of metabolic function

Award Number: R01DK138586
ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/20/2024
PERIOD OF PERFORMANCE END DATE: 12/31/2027
AWARD TERMINATION DATE: 04/30/2025

Group Awards By:

View Award Description

Alpha2/delta1- thrombospondin-3 signaling in the central control of metabolic function - Project Summary Brain-derived neurotrophic factor (BDNF) and its receptor TrkB play essential roles in the central regulation of energy and glucose homeostasis. BDNF signaling greatly influences many aspects of neuronal function, including survival, differentiation and synaptic plasticity and transmission. Deficits in BDNF function have been linked to over feeding and severe obesity in humans and mice. Accordingly, we showed that mice with BDNF depletion in the brain (BDNF2L/2LCk-cre) exhibit increased food intake, obesity, insulin resistance and dyslipidemia. Diminished a2d-1 (Cacna2d1) function in ventromedial hypothalamus (VMH) of BDNF2L/2LCk-cre mice contributes to the metabolic alterations that they exhibit. In support, viral-mediated rescue of deficient a2d-1 expression in the VMH of BDNF2L/2LCk-cre mice mitigated their hyperphagia and obesity. Importantly, it dramatically improved hepatic lipid accumulation and normalized deficits in glycemic control even though rescued mutants remained significantly heavier than wild type controls. Furthermore, a2d-1 knock down in the adult VMH resulted in susceptibility to diet-induced obesity (DIO). a2d-1 serves as a receptor for astrocyte- derived thrombospondins (TSP) to mediate excitatory synapse assembly. Electrophysiological analysis indicates that the metabolic effects of a2d-1 are related changes in the excitatory tone onto VMH neurons, implicating thrombospondin signaling. This project will test the hypothesis that TSP/a2d-1 signaling in the VMH facilitates synaptic remodeling during conditions of positive energy balance to increase the excitatory drive onto neurons mediating energy, glucose and lipid homeostasis. Aim 1 will determine how gain or loss of a2d-1 function in the adult VMH affects metabolic function and mechanisms activated by a2d-1 that prevent hepatic steatosis and glucose intolerance during obesogenic conditions. Aim 2 will examine the effects of gain or loss of astrocytic TSP function in the adult VMH in the regulation of metabolic function and whether these effects are a2d-1-dependent. Aim 3 will determine whether a2d-1 and TSP mediates the effects of caloric status on the excitatory synaptic physiology and activity of VMH neurons. Finally, Aim 4 will map the connectivity of VMH a2d-1+ neurons, examine their responses to caloric signals in vivo and the effects of stimulating or inhibiting these cells on metabolic function. Findings from this project will inform novel mechanisms facilitating metabolic health in individuals who are persistently overweight and new targets for the treatment of metabolic dysfunction. Importantly, they have the potential to inform pathological mechanisms underlying metabolic disturbances in individuals administered the anti-epileptic and anti- nociceptive drugs gabapentin and pregabalin, which bind and inhibit a2d-1.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $561,761 )
2026	2026	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	3	1/8/2026	NON-COMPETING CONTINUATION	$561,761
														Subtotal = $561,761

Issue Date FY: 2025 ( Subtotal = $561,761 )
2025	2025	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	002	2	6/17/2025	NON-COMPETING CONTINUATION	$56,175
2025	2025	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	2	1/8/2025	NON-COMPETING CONTINUATION	$505,586
2025	2024	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	1	4/29/2025	TERMINATION	$0
														Subtotal = $561,761

Issue Date FY: 2024 ( Subtotal = $574,802 )
2024	2024	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	001	1	8/20/2024	SUPPLEMENT FOR EXPANSION	$32,222
2024	2024	TRUSTEES OF TUFTS COLLEGE	136 HARRISON AVE	BOSTON	MA	02111	SUFFOLK	USA	Diabetes, Digestive, and Kidney Diseases Extramural Research	000	1	3/19/2024	NEW	$542,580
														Subtotal = $574,802

Grand Total All Awards = $1,698,324

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Alpha2/delta1- thrombospondin-3 signaling in the central control of metabolic function

Award Number: R01DK138586

ORGANIZATION: NATIONAL INSTITUTE OF DIABETES & DIGESTIVE & KIDNEY DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/20/2024

PERIOD OF PERFORMANCE END DATE: 12/31/2027

AWARD TERMINATION DATE: 04/30/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer